Turning KRAS into a Molecular Trigger: Covalent-Induced Drug Conjugates for Conditional Tubulin Poisoning

Authors: Renner, Anna C; Kargbo, Robert B

Source journal: ACS medicinal chemistry letters (2026-11-12)

DOI: 10.1021/acsmedchemlett.6c00531

Abstract

Covalent-induced drug conjugates introduce a provocative precision-oncology strategy: mutant KRAS serves not merely as the therapeutic target but as the molecular trigger for drug release. By coupling KRAS(G12C) recognition to intracellular release of potent tubulin inhibitors, this strategy seeks to convert oncogene engagement into localized cytotoxicity while limiting systemic payload exposure.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.